HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer. - Ruiz-Lorente I; Gimeno L; López-Abad A; Cubillana PL; Aparicio TF; Egea LJA; Avilés JM; Iñiguez GD; Martínez-Valls PLG; Server G; Ferri B; Campillo JA; et al. (Oncoimmunology, 2025)